XML 38 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Employee Benefit Plans (Tables)
3 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

 

 

September 30,
2025

 

 

June 30,
2025

 

2013 Equity Incentive Plan shares available for grant

 

 

6,276

 

 

 

10,935

 

Employee stock options and awards outstanding

 

 

9,060

 

 

 

7,566

 

2014 Employee Stock Purchase Plan

 

 

5,418

 

 

 

5,952

 

Total shares reserved for issuance

 

 

20,754

 

 

 

24,453

 

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):

 

 

Three Months Ended

 

 

 

September 30,
2025

 

 

September 30,
2024

 

Cost of product revenues

 

$

752

 

 

$

618

 

Cost of subscription and support revenues

 

 

727

 

 

 

689

 

Research and development

 

 

4,447

 

 

 

4,213

 

Sales and marketing

 

 

7,513

 

 

 

6,882

 

General and administrative

 

 

8,341

 

 

 

7,365

 

Total share-based compensation expense

 

$

21,780

 

 

$

19,767

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the three months ended September 30, 2025 (in thousands, except per share amount and contractual term):

 

 

Number of Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Options outstanding at June 30, 2025

 

 

496

 

 

$

6.70

 

 

 

1.16

 

 

$

5,580

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(71

)

 

 

6.70

 

 

 

 

 

 

 

Canceled

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at September 30, 2025

 

 

425

 

 

$

6.70

 

 

 

0.91

 

 

$

5,923

 

Vested and expected to vest at September 30, 2025

 

 

425

 

 

$

6.70

 

 

 

0.91

 

 

$

5,923

 

Exercisable at September 30, 2025

 

 

425

 

 

$

6.70

 

 

 

0.91

 

 

$

5,923

 

Summary of Stock Award Activity

The following table summarizes stock award activity for the three months ended September 30, 2025 (in thousands, except grant date fair value):

 

 

Number of Shares

 

 

Weighted- Average Grant Date Fair Value

 

 

Aggregate Fair Value

 

Non-vested stock awards outstanding at June 30, 2025

 

 

7,070

 

 

$

19.53

 

 

 

 

Granted

 

 

4,129

 

 

 

19.57

 

 

 

 

Released

 

 

(2,520

)

 

 

18.85

 

 

 

Canceled

 

 

(44

)

 

 

19.56

 

 

 

 

Non-vested stock awards outstanding at September 30, 2025

 

 

8,635

 

 

$

19.73

 

 

 

 

Stock awards expected to vest at September 30, 2025

 

 

8,635

 

 

$

19.73

 

 

$

170,378

 

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards The following assumptions used to determine the grant-date fair values of the MSU during the following periods:

 

 

Three Months Ended

 

 

 

September 30,
2025

 

 

September 30,
2024

 

Expected term

 

3.0 years

 

 

3.0 years

 

Risk-free interest rate

 

 

3.70

%

 

 

3.86

%

Volatility

 

 

45

%

 

 

48

%

Dividend yield

 

 

%

 

 

%

 

The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

 

 

Employee Stock Purchase Plan

 

 

 

Three Months Ended

 

 

 

September 30,
2025

 

 

September 30,
2024

 

Expected term

 

0.5 years

 

 

0.5 years

 

Risk-free interest rate

 

 

4.12

%

 

 

5.04

%

Volatility

 

 

50

%

 

 

36

%

Dividend yield

 

 

%

 

 

%